Sonophotodynamic therapy mediated by liposomal zinc phthalocyanine in a colon carcinoma tumor model: Role of irradiating arrangement

Document Type : Original Article


1 Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran

3 Medical Physics Department, Reza Radiation Oncology Center, Mashhad, Iran

4 Department of Biostatistics & Epidemiolog, School of Health, Management & Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

5 Department of Medicinal Chemistry, Mashhad University of Medical Sciences, Mashhad, Iran

6 Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran


Objective(s): Low penetration depth of light is the main defect of photodynamic therapy (PDT), which could be improved by sonodynamic therapy (SDT). In this study, a combination of PDT and SDT known as sonophotodynamic therapy (SPDT) was investigated using two reverse arrangements in CT26 tumor model.
Materials and Methods: The liposomal zinc phthalocyanine was synthesized and characterized. It was then administered to CT26 tumor models as a sensitizer.  The animal models were subjected to PDT, SDT, and the combined treatment in different groups. The doubling time for the survival of tumors and animals was considered as a measure to evaluate treatments efficacy.
 Results: In all treatment groups there was a significant decline in tumor volume 15 days after treatment compared to the main control group, but the optimum response was observed in the group receiving a combined treatment with the priority of PDT. 120 days after treatment, in the groups treated by PDT and SDT, the tumor shrank by 20%, while in the group receiving SPDT with PDT priority, 80% of tumors was recovered. No case of complete tumor progression was observed in SPDT group with SDT priority.This could be due to the pores created in cell membranes during ultrasound irradiation of the tumor, which removed the sensitizer molecules from the cells and reduced PDT efficacy in SPDT group with SDT priority. 
Conclusion: It seems that SPDT with PDT priority offers a more efficient alternative than each of PDT, SDT individually or SPDT with the reverse arrangement.


1. Bakhshizadeh M, Sazgarnia A, Rajabi O, Khooei AR,Esmaily H. Effects of combined sonodynamic and photodynamic therapies on a colon carcinoma tumor model. Iran J Basic Med Sci  2011; 14: 205-212.
2. Huang Z . A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat  2005; 4:283-293.
3. Brendan GB, Quirka J, Donlonb S, Verab JC,  Mangc S, Andrew B, et al. Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? Photodiagnosis Photodyn Ther 2015;12: 530-544.
4. Miyoshi N, Mišík V, Fukuda M, Riesz P. Effect of gallium-porphyrin analogue ATX-70 on nitroxide formation from a cyclic secondary amine by ultrasound: on the mechanism of sonodynamic activation. Rad Res 1995; 143:194-202.
5. Xiaohuai Wang WZ, Zhiyong X, Luo Y, Mitchell M. Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of  3 cases. Integr Cancer Ther 2009; 8:283–287.
6. Jori G, Fabris C. Relative contribution of apoptosis and random necrosis in tumor response to photodynamic therapy: Effects of the chemical structure of Zn(II) Phtalocyanines. J Photochem Photobiol B 1998; 43:181-185.
7. Milowska K, Gabryelak T. Synergistic effect of ultrasound and phthalocyanines on nucleated erythrocytes in vitro. Ultrasound  Med Biol 2005; 31:1707-1712.
8. Yumita N, Okuyama N, Sasaki K, Umemura SI. Umemura; Sonodynamic therapy on chemically induced mammary tumor: Pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of porfimer sodium. Cancer Sci 2004; 95:765-769 .
9. Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy: a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem  2004; 11:349-363.
10. Yasui A, Haga Y, Chen J,Wada H. Focused ultrasonic device for sonodynamic therapy in the human body, in Microtechnology in Medicine and Biology, 2005. 3rd IEEE/EMBS Special Topic Conference on. 2005. IEEE.
11. Yumita Y, Umemura S. Sonodynamic therapy with photofrin II on AH130 solid tumor. Cancer Chemother Pharmacol 2003; 51:174-178.
12. Sazgarnia A, Shanei A,  Meibodi NT, Eshghi H, Nassirli H. A novel nanosonosensitizer for sonodynamic therapy. J Ultrasound Med 2011; 30:1321-1329.
13. Kenyon JN, Fulle RJ,Lewis TJ. Activated cancer therapy using light and ultrasound-a case series of sonodynamic photodynamic therapy in 115 patients Over a 4 Year Period. Curr Drug Ther 2009; 4:179-193.
14. Liu Q, Wang X, Wang P, Xiao L.Sonodynamic antitumor effect of protoporphyrin IX disodium salt on S180 solid tumor. Chemotherapy 2007; 53:429-436.
15. Payne TP, Ambrose CV, Ward MD, Ridgway F. Proliposomes: A novel solution to an old problem. Pharm Sci 1986; 75.
16. Li C, Deng Y. A novel method for the preparation of liposomes: Freeze drying of monophase solutions, J Pharm Sci 2004; 93:1403-1414.
17. Jin ZH, Ishiguro K, Umemura S, Kawabata K, Yumita N, Sakata I, et al. Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinoma in C3H/HeN mice. Dermatal 2000; 27:294-306.
18. Liu Y, Wang P, Liu Q,Wang X. Sinoporphyrin sodium triggered sono-photodynamic effects on breast cancer both in vitro and in vivo. Ultrason Sonochem 2016; 31:437-448.